Aurelia Healthcare — Project Overview

The platform architecture and the three-phase build — Aurelia Medical City in Johannesburg, regional specialist hospitals and the integrated healthcare ecosystem — and the platform scale at stabilization.

Aurelia Healthcare Business PlanSection 2 › Project Overview

Section 2 · Business Plan

Project Overview

The platform architecture and the three-phase build — Aurelia Medical City in Johannesburg, regional specialist hospitals and the integrated healthcare ecosystem — and the platform scale at stabilization.

2.1 Platform Architecture

Aurelia Healthcare Group will be developed as a three-phase, ten-year
capital programme designed to assemble a defensible,
geographically-diversified, clinically-integrated platform. The phasing
approach allows capital to be deployed in disciplined tranches with
clear go/no-go gates, while creating early operational cash flow from
the flagship facility to partially de-risk subsequent phases.

2.2 Phase I — Aurelia Medical City, Johannesburg (Years 1–3)

The flagship development is conceived as a world-class integrated
academic medical city located in the Sandton-Modderfontein corridor —
South Africa’s densest concentration of insured population,
multinational corporate headquarters, and tertiary specialist
clinicians. Site selection prioritises proximity to the M1 highway, OR
Tambo International Airport (medical tourism corridor), and
complementary tertiary infrastructure.

Phase I — Facility Composition

Component Specification Capex (USD M)
Tertiary Inpatient Hospital 420 acute beds (incl. 60 ICU/HDU) 78.0
Operating Theatre Suite 18 theatres (incl. 2 hybrid OR, 4 robotic-ready) 14.5
Level 1 Trauma & Emergency Centre 24/7 trauma bays, helipad, CT-in-resus 8.5
Cardiac Institute Cath labs, EP suite, structural heart programme 11.0
Oncology Institute Linac vault (×3), brachytherapy, day chemo 12.5
Women & Children’s Hospital 60 maternity beds, NICU, paeds ICU 7.0
Renal & Transplant Centre 30-station dialysis, transplant theatre 4.5
Diagnostic Imaging Hub 3T MRI ×2, CT ×3, PET-CT, DEXA, fluoroscopy 6.0
Teaching & Simulation Centre High-fidelity simulators, lecture halls 2.5
Land, civils, soft costs, contingency 0.5
Total Phase I Capex 145.0

2.3 Phase II — Regional Specialist Hospitals (Years 3–5)

Phase II extends the platform into three further metropolitan
markets, leveraging the brand equity, clinical protocols, technology
backbone, and back-office shared services of the Johannesburg flagship
to drive faster ramp-up and superior unit economics. Site selection is
informed by gravity modelling against insured population density,
specialist supply gaps, and competitor catchment overlap.

Facility Beds Theatres Specialty Focus Capex (USD M)
Cape Town Specialist Hospital (Century City / Tygervalley) 150 12 Cardiac, oncology, orthopaedic 26.0
Durban Specialist Hospital (Umhlanga / Ridgeside) 140 11 Trauma, cardiac, hepatobiliary 23.0
Pretoria Medical Centre (Menlyn / Waterkloof) 160 10 Government corporate, oncology, women’s health 23.0
Phase II Total 450 33 72.0

2.4 Phase III — Integrated Healthcare Ecosystem (Years 5–8)

The ecosystem build-out converts Aurelia from a hospital group into
an integrated healthcare platform, capturing patient flow upstream
(primary care, screening) and downstream (rehabilitation, chronic care,
telehealth) of the acute episode. The strategic rationale is threefold:
(i) lower customer acquisition cost via owned referral channels; (ii)
higher lifetime value per patient through longitudinal continuity; and
(iii) defensive moat against NHI fee compression by capturing service
margin across the care pathway.

  • Outpatient & Day-Hospital Network: 14 sites
    in metropolitan and growth-corridor locations, branded under “Aurelia
    Care”, offering same-day surgery, outpatient consults, minor procedures,
    and preventative health.
  • Dialysis Network: 11 dedicated dialysis centres
    co-located with high-density renal-failure catchments, contracted to
    medical schemes and (subject to accreditation) NHI from
    inception.
  • Oncology Satellite Clinics: 6 satellite
    chemotherapy and infusion centres operating under hub-and-spoke clinical
    governance from the flagship Oncology Institute.
  • Diagnostic Laboratories: Joint-venture pathology
    and molecular diagnostics laboratories with one of the established South
    African pathology majors, embedded in the EMR for closed-loop result
    reporting.
  • Telemedicine & Digital Health: AurelaConnect
    platform offering scheduled and on-demand telehealth, e-prescriptions,
    remote chronic-disease monitoring, and behavioural-health
    programmes.
  • AI-Enabled Radiology: Cloud-based AI triage and
    reporting for stroke, pulmonary embolism, intracranial haemorrhage,
    fracture, and breast-cancer screening, deployed across all in-network
    imaging.
  • Occupational Healthcare Contracts: Site-based
    occupational health services for major mining, manufacturing, and
    corporate clients, embedded with a corporate wellness offering.
Figure 2.1
Figure 2.1 — Capital deployment schedule by phase showing hospital capex, working capital, and contingency provisions

2.5 Platform Scale at Stabilization

At full stabilization in Year 6+, the platform will operate at the
following scale, positioning Aurelia as the credible “fourth force” in
South African private hospital services and the most digitally-mature
operator in the market.

Metric Phase I Stabilized Phase II Stabilized Group at Stabilization
Total Beds 420 450 870
ICU / HDU Beds 60 85 145
Operating Theatres 18 33 51
Linear Accelerators 3 2 5
Dialysis Stations 30 48 78 (+ 220 in network)
Annual Patient Interactions 0.42 M 1.08 M 1.5 M+
Total Workforce 2,400 3,800 7,360
Affiliated Doctors 350 430 780+
Outpatient Sites (network) 0 0 14
Diagnostic Sites (network) 1 3 8

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Aurelia Healthcare Holdings (Pty) Ltd.